ASGE Annual GI Advanced Practice Provider Course (Virtual) - Onboarding (Day One) | March 2023-Management of Anti-Thrombotic Agents for Patients Undergoing GI Endoscopy

Video Transcription

Video Summary

This video is a comprehensive review of the bleeding risk of endoscopic procedures and how to manage patients on antithrombotic agents during these procedures. The presenter highlights that about 40% of adults in the United States take at least one antithrombotic for a cardiovascular condition. The risk of GI bleed in cardiac patients increases with age, with a one in five risk of developing GI bleed in patients over 75 years old on both an anticoagulant and antiplatelet agent. The presenter mentions that ED visits for GI bleeding have increased by 17% in the last 10 years for all ages. The video discusses various guidelines for managing antithrombotics during endoscopic procedures, including those by the American College of Gastroenterology, Canadian Association of Gastroenterology, European Society of Gastrointestinal Endoscopy, and British Society of Gastroenterology. The presenter emphasizes the importance of assessing bleeding risk based on the nature of the procedure, the patient's thromboembolic standpoint, and the antithrombotic medication. They also discuss specific considerations for anticoagulants, antiplatelets, and direct oral anticoagulants (DOACs). The video concludes with recommendations for resumption of antithrombotic medications post-procedure and strategies for managing high-risk patients who cannot discontinue antithrombotics.

Asset Subtitle

Sarah Enslin, PA-C

Keywords

bleeding risk

endoscopic procedures

antithrombotic agents

GI bleed

guidelines